• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

GPs key in ensuring the new Faster Diagnosis Standard for Cancer is a success

Bioengineer by Bioengineer
March 25, 2019
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GPs will have a pivotal role in ensuring the success of the new Faster Diagnosis Standard (FDS) for Cancer, new research from the University of Surrey finds.

In the first study of its kind, published today in the British Journal of General Practice and funded by Cancer Research UK, researchers investigated public attitudes towards the new FDS for Cancer. Scheduled to be introduced in England next year, this new standard will give patients a diagnosis or all-clear for cancer within 28 days of referral with suspected cancer.

Conducting focus group sessions in Bradford and Guildford with participants who in the last six months had undergone diagnostic tests for cancer and received results, researchers identified a degree of scepticism amongst the groups about how the new standard would work. Many participants had experienced swift referrals for diagnostic testing but encountered a delay when receiving test results and were unsure about how the FDS would rectify this.

Concern existed amongst participants that the FDS may ultimately extend waiting times and could become more of a ‘tick box’ exercise, with one participant noting:

‘So what happens is that as soon as 28 days appears anywhere that becomes the standard, rather than the last resort, so when suddenly you go, well we’ve got 28 days, we’ll give them a … we’ll get in touch with them in three weeks’ time […].’

Participants also described a lack of transparency in the referral process and were apprehensive about getting lost in the system. This feeling was exacerbated by not knowing what to expect and/or being unable to draw upon past experiences due to inconsistency between one referral and the next.

Interestingly, researchers found that participants valued reassurance and support from their GP as highly as a speedy referral. A feeling of being listened to by a GP was found to be important to participants when being referred for diagnostic tests.

‘Being listened to I think, so it’s being heard and my GP was fine, has really really been… it was really quick, it couldn’t have been quicker, but it was feeling… I suppose it’s being listened to and then almost like being believed.’

Dr Katriina Whitaker, Reader in Cancer Care at the University of Surrey, said: “The new Faster Diagnosis Standard for Cancer is an important step in diagnosing cancer earlier and faster. However we have found that although patients value a speedy referral there are other factors that they regard as just as important.

“Simple steps such as informing patients about the diagnostic testing and referral processes and about time scales will help patients better prepare, both physically and emotionally, for the next phase. This will ultimately fall to GPs, who will need clear guidance so they are able to support their patients.”

Dr Jodie Moffat from Cancer Research UK said: “We need to redouble our efforts to reduce the late stage diagnosis of cancer, so that more people survive their disease. Reducing late stage diagnosis of cancer requires action on a range of fronts, and we all have a part to play. Ensuring there’s enough workforce in the system – whether that’s in primary care or in hospitals – is vital to achieving our early diagnosis ambitions.”

###

Media Contact
Natasha Meredith
[email protected]
http://dx.doi.org/10.3399/bjgp19X702677

Tags: cancerClinical TrialsHealth Care Systems/ServicesHealth ProfessionalsMedicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

blank

Gemcitabine, Cisplatin, Durvalumab for Biliary Cancer: Insights

August 24, 2025
blank

Long Non-Coding RNAs in Hormone-Driven Cancers

August 24, 2025

Breaking Barriers: Drug Repurposing Advances in Oncology

August 24, 2025

Breast Cancer Recurrence: Insights from Addis Ababa Study

August 24, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    131 shares
    Share 52 Tweet 33
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Snake Secretions Repel and Poison Ants

Climate Change Effects on Northern Ethiopia’s Farmers

Exploring Multi-Dimensional Depths of Metagenomics

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.